{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T17:28:22Z","timestamp":1649006902281},"reference-count":12,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2011,7,30]],"date-time":"2011-07-30T00:00:00Z","timestamp":1311984000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urologe"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1007\/s00120-011-2655-y","type":"journal-article","created":{"date-parts":[[2011,7,28]],"date-time":"2011-07-28T14:01:53Z","timestamp":1311861713000},"page":"1383-1386","source":"Crossref","is-referenced-by-count":0,"title":["Osteoporoseprophylaxe unter Androgendeprivationstherapie"],"prefix":"10.1007","volume":"50","author":[{"given":"N.","family":"Rolfes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"L\u00fcmmen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,7,30]]},"reference":[{"key":"2655_CR1","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1007\/s00120-009-2073-6","volume":"48","author":"Rolfes","year":"2009","unstructured":"Rolfes N, L\u00fcmmen G (2009) Der Stellenwert von Bisphosphonaten in der Therapie des Prostatakarzinoms. Urologe 48:990\u2013996","journal-title":"Urologe"},{"key":"2655_CR2","unstructured":"Heidenreich A, Bolla M, Joniau S et al (2011) Guidelines on prostate cancer. European Association of Urology, Arnheim, http:\/\/www.uroweb.org\/guidelines\/online-guidelines"},{"key":"2655_CR3","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.coph.2005.06.005","volume":"5","author":"Kostenuik","year":"2005","unstructured":"Kostenuik PJ (2005) Osteoprotegerin and RANKL regulate bone resorption, density, geometry and strength. Curr Opin Pharmacol 5:618\u2013625","journal-title":"Curr Opin Pharmacol"},{"key":"2655_CR4","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJMoa0809003","volume":"361","author":"Smith","year":"2009","unstructured":"Smith MR, Egerdie B, Hernandez Toriz N et al (2009) Denosumab in men receiving androgen-deprivation therapy for prostate cancer. N Engl J Med 361:745\u2013755","journal-title":"N Engl J Med"},{"key":"2655_CR5","doi-asserted-by":"crossref","first-page":"4426","DOI":"10.1200\/JCO.2007.15.1233","volume":"26","author":"Greenspan","year":"2008","unstructured":"Greenspan SL, Nelson JB, Trump DL et al (2008) Skeletal health after continuation, withdrawal, or delay of aledronate in men with prostate cancer undergoing androgen-deprivation therapy. J Clin Oncol 26:4426\u20134434","journal-title":"J Clin Oncol"},{"key":"2655_CR6","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/j.1464-410X.2007.06853.x","volume":"100","author":"Ryan","year":"2007","unstructured":"Ryan CW, Huo D, Bylow K et al (2007) Suppression of bone density loss and bone turnover in patients with hormone-sensitive prostate cancer and receiving zoledronic acid. BJU Int 100:70\u201375","journal-title":"BJU Int"},{"key":"2655_CR7","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1097\/01.ju.0000063820.94994.95","volume":"169","author":"Smith","year":"2003","unstructured":"Smith MR, Eastham J, Gleason DM et al (2003) Randomized controlled trial of zoledronic acid to prevent bone loss in men receiving androgen deprivation therapy for nonmetastatic prostate cancer. J Urol 169:2008\u20132012","journal-title":"J Urol"},{"key":"2655_CR8","unstructured":"Deutsche Gesellschaft f\u00fcr Urologie (2009) Interdisziplin\u00e4re Leitlinie der Qualit\u00e4t S3 zur Fr\u00fcherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms. DGU, D\u00fcsseldorf, http:\/\/www.krebsgesellschaft.de\/download\/s3-leitlinie-prostatakarzinom.pdf"},{"key":"2655_CR9","unstructured":"Hyslop J, Paul A, Seddon J et al (2008) Prostate cancer: diagnosis and treatment, full guideline. National Institute for Health and Clinical Excellence (NICE), http:\/\/www.nice.org.uk\/Guidance\/CG58"},{"key":"2655_CR10","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1001\/jama.2011.190","volume":"305","author":"Park-Wyllie","year":"2011","unstructured":"Park-Wyllie LY, Mamdani MM, Juurlink DN et al (2011) Bisphosphonate use and the risk of subtrochanteric or femoral shaft fractures in older women. JAMA 305:783\u2013789","journal-title":"JAMA"},{"key":"2655_CR11","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s00198-010-1453-5","volume":"22","author":"Rizzoli","year":"2011","unstructured":"Rizzoli R, Akesson K, Bouxsein M et al (2011) Subtrochanteric fractures after long-term treatment with bisphosphonates: A European Society on Clinical and Economic Aspects of Osteoporosis and Osteoarthritis, and International Osteoporosis Foundation Working Group Report. Osteoporos Int 22:373\u2013390","journal-title":"Osteoporos Int"},{"key":"2655_CR12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"Boyle","year":"2003","unstructured":"Boyle WJ, Scott Simonet W, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337\u2013342","journal-title":"Nature"}],"container-title":["Der Urologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-011-2655-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00120-011-2655-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00120-011-2655-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T15:48:16Z","timestamp":1558626496000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00120-011-2655-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,7,30]]},"references-count":12,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["2655"],"URL":"https:\/\/doi.org\/10.1007\/s00120-011-2655-y","relation":{},"ISSN":["0340-2592","1433-0563"],"issn-type":[{"value":"0340-2592","type":"print"},{"value":"1433-0563","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,7,30]]}}}